In addition, we demonstrated that altered PDK1 expression is enough for the deactivation of the PI3K/PDK/AKT/mTOR oncogenic signaling and sensitizes aggressive HCC cells to radiotherapy (Figure 2). The gene discussed is AKT1; the disease is hepatocellular carcinoma.